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Introduction
Diabetic retinopathy (DR) is a serious microvascular 
complication of diabetes which leads to vision loss or 
blindness ultimately. In fact, it is one of the most frequent 
causes of visual impairment in the world.1 Signs of DR are 
retinal vascular permeability and retinal ischemia. Since 
progression of DR are accompanied with biochemical, 
cellular and histopathological changes that are not 
detectable by the clinician, molecular investigation is 
an important requirement.2 It is reported that in DR 
genetic, environmental, and immunological factors 
act together.3,4 The main process affected in patients is 
hyperglycemia. Chronic high levels of blood glucose in 
diabetic patients effect destructively on retina because 
retina cells are sensitive to overflow of glucose. One of 
the complications of DR is vascular permeability changes 
which plays an important role in the development of 
visual impairment in diabetes. Non enzymatic glycation 
of proteins leads to advanced glycation end products 
(AGEs). AGEs are able to produce cross-links between 
proteins.5,6 In vitro and in vivo investigation have proven 
the relationship between AGEs concentration and DR 
signs.7 Diabetic condition induces some alterations in 
the expression of a diverse range of retinal proteins, so 
study of biochemical pathways may provide valuable 
insights into the pathogenesis of DR.8 Protein complexes 
are known as essential components in cellular processes 
and analysis of the proteins in these complexes is a state 
of art approach.9 Protein- protein interaction network 
analysis in pathophysiological conditions attracted 
significant attention from researchers, in order to discover 
an integrated biological output.10 Human molecular 
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Abstract
Introduction: Diabetic retinopathy (DR) is a serious microvascular complication of diabetes 
which can cause vision loss or blindness ultimately. Non enzymatic glycation of proteins leads 
to advanced glycation end products (AGEs) in DR.  Since laser therapy is a well-established 
method, in this study, protein-protein interaction (PPI) network is applied for protein targets in 
DR disease in rats treated by laser. 
Methods: In this study, we focused on articles that investigated and compared the proteome 
profiles of DR rats with healthy control and also DR rats before and after laser therapy. The 
networks of related differentially expressed proteins were explored using Cytoscape version 
3.3.0, the PPI analysis methods and ClueGO.
Results: Analysis of PPI network of 37 related proteins to DR rats including 108 nodes, introduced 
10 hub-bottleneck proteins and 5 concerned biochemical pathways. On the other hand, PPI 
analysis of related proteins to DR rats before and after laser therapy corresponded to 33 proteins 
and 2 biological pathways. 
Discussion: Centrality and cluster screening identified hub-bottelneck genes, including Aldoa, 
HSPD1, Pgam2, Mapk3, SLC2A4, Ctnnb1, Ywhab, HSPA8, GAPDH and Actb for DR rats versus 
healthy control and ENO1, Aldoa, GAPDH for DR samples after laser therapy. 
Conclusion: Gene expression analysis of the DR samples treated via laser therapy provides a 
molecular evidence in support of the therapeutic effect of laser.
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interaction networks are not just basic science exercise for 
a more clear view of fundamental human biology but will 
transform molecular diagnosis, treatment and patients 
monitoring tools.11-13 Protein networks analysis provides 
a scientific model that can improve understanding of the 
mechanisms underlying human diseases.14-19 Pathogenesis 
of DR is complex, and despite a lot of research, it has 
not been completely elucidated. Published evidence 
supported clinical use of lasers for the proliferative DR 
macular edema.20 The importance of early treatment 
of DR depends on the level of knowledge in molecular 
changes and cellular processes.21,22 Identification and 
comparison of the protein-protein interaction (PPI) 
changes and involved pathways in the diabetic retina 
before and after laser will provide clues to the underlying 
therapeutic mechanism(s) involved in laser treatment as 
well as other diseases.17,18,23 Laser therapy is used as an 
anti-VEGF treatment of DR patients but this therapeutic 
method may cause retinal damage and scarring.24 
Discovery of molecular interventions and understanding 
disease processes can be helpful in introducing less 
invasive therapeutic options. In this study, we want to 
analyze PPI network to identify critical proteins and 
signaling pathways related to diabetic nephropathy and 
also in response to laser therapy. It is aimed to reveal 
common molecular changes in DR pathogenesis and 
following laser therapy. 
Methods
Selection of Differentially Expressed Genes
The PubMed database and Google Scholar were 
cross-searched (on June 2015) for the terms “diabetic 
retinopathy” ,“proteomic”, “laser”, and “treatment” (i.e., 
title, abstract, keyword). A total of 25 research papers 
were collected which surveyed tissues, serum, plasma, 
saliva and urine. Among them, studies with focus on 
same organism and same cell-position before and after 
treatment were selected. Finally, a study that had surveyed 
proteome map of normal rat retina in comparison with 
the proteome of diabetic rat retina was selected25 (Table 1) 
and another one focusing on protein changes in rats after 
laser treatment26 (Table 2). 
Construction and Topological Analysis of PPI Networks
PPI networks were generated using Cytoscape version 
3.3.0.27 The advantage of Cytoscape is that users can 
analyze and visualize networks of genes and compounds, 
and identify enriched pathways from expression profiling 
data. Two centrality parameters such as degree and 
betweenness were considered to determine the hub and 
bottleneck proteins. First, we prepared the list of proteins 
which were hub in PPI network of DR versus controls in 
the PPI network. The nodes with high degree defined as 
hub proteins and the nodes with high betweenness defined 
as bottleneck proteins, which both play pivotal roles in 
the network.28 The results indicate that some hub nodes 
play a role as bottleneck, these proteins were introduced 
Table 1. Thirty-Seven Changed Expression Proteins in Retina of Rats 
With Diabetic Retinopathy in Comparison With Healthy Control Rats
Protein Name Gene Name
Enolase 2 gamma ENO2
Heat shock protein 70 1A HSPA1A
Heat shock protein 8 HSPA8
Aldehyde reductase 1 AKR1B1




Beta catenin complex B Ctnnb1







Proteasome alpha 6 subunit Psma6
Phosphoglycerate mutase Pgam
Aminoacyclase 1 Acy1a
Succinyl CoA ligase ADP forming subunit Suclg1
Dystrophin-related protein 2 DRP 2
Inositol 1 monophosphate Impa1
Triosephosphate isomerase Tpi1
Chaperonin subunit 2 Hspd1
ATP synthase B subunit Atp5b
Tubulin beta TUBB3
Histone 2B Hist1h2ba






Glutamate ammonia ligase Glul
Fructose bisphosphate aldolase A Aldoa
Superoxide dismutase Sod1
Isovaleryl coenzyme A dehydrogenase Ivd
as hub-bottleneck. ClueGO was used for data analysis. 
The degree of functional enrichment for a given cluster 
was quantitatively assessed (statistical significance was 
calculated) using the ClueGO tool.29 ClueGO integrates 
gene ontology (GO) terms and creates a functionally 
organized GO/pathway term network. It can analyze 
genes and comprehensively visualize functionally grouped 
terms.29 A pack of gene annotations (e.g. functions, 
processes) can help identify interesting features, but due 
to the huge size of the sets, selecting statistically significant 
trends from large datasets is impractical. Thus, a method 
is required for the routine analysis of such datasets. We 
used GO as a common vocabulary for annotation as it 
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allows identification of semantically related genes and 
gene products.30 Kappa statistic ≥0.4, enrichment and 
Bonferroni step down method were used for probability 
value correction.31
Laser Parameters
The laser (20 spots of 100-mW power, 200-μm diameter, 
0.1 ms) which has been used in rat DR studies was Argon 
green with a wavelength of 514 nm slit-lamp laser (HGM 
Medical Laser Systems Inc., USA). The one eye of the 
rat DR samples was treated by laser under anaesthesia 
condition.26
Results
Topological Analysis of PPI Networks for Diabetic 
Retinopathy vs. Normal Rats
Cytoscape analysis revealed a great number of close 
interconnections (see Figure 1). The PPI network 
properties are tabulated in Table 3. The top 10% proteins 
in terms of degree and betweenness (2) were defined as 
hubs and bottlenecks respectively. These key proteins are 
tabulated in Table 4. As it is depicted in Table 4 all hub 
proteins play a role as bottlenecks too; so we introduced 
them as hub-bottleneck proteins. The GO pathway 
clusters enriched by crucial proteins in DR rats versus 
healthy controls are shown in Table 5.
PPI Network Analysis for Diabetic Retinopathy Rats 
Before and After Laser Therapy
The results of network analysis in subpart 3.1 and the 
results of PPI network analysis related to DR rats before 
and after laser therapy are shown in Figure 2 and Tables 
6-8.
Discussion
As mentioned in Methods, 37 differentially expressed 
proteins are associated with DR rats (disease state). 
However, 12 proteins differentiate the treated samples 
from DR rats (treated state). The information is tabulated 
in Tables 1 and 2. Furthermore, networks corresponding 
to disease and treated states are analyzed and presented in 
Figures 1 and 2. As illustrated in these figures, disease state 
network consists of 108 nodes while treated state network 
includes 33 nodes. Both networks are about three folds 
wider than the initial proteins. In addition, about half of 
the nodes of the 2 networks are multi-edges. At the first 
glance, as presented in Tables 3 and 6, on average the 2 
networks are 40% different. However, based on average 
betweenness, the networks are 5 folds dissimilar. Other 
Table 2. A Number of Changed Expression Proteins in Retina of Rats 
With Diabetic Retinopathy Before and After Laser Therapy
Protein Name Gene Name
Alpha-A crystalline Cryaa
Recoverin Rcvrn
Isovaleryl coenzyme A dehydrogenase Ivd
Claudin-12 Cldn12
Enolase 1 alpha Eno1
Germinal histone H4 Hist1h4b






Figure 1. PPI network which consists of 108 nodes and 56 multi-edge 
node pairs for diabetic retinopathy versus normal rats. The larger 
circles correspond to the higher degree and blue to brown color refers 
to increment of betweenness value
Table 3. Properties of protein-protein interaction Network of Diabetic 
Retinopathy Versus  Normal Rats
Topological Parameters Values
Number of nodes 108
Multi-edge node pairs 56
Average degree 4.981
Average betweenness 0.023
Average closeness centrality 0.309
Network density 0.029
Table 4. The Hub-Bottleneck Nodes in the Protein Network of Diabetic 
Retinopathy Versus Normal Rats
Gene Name Degree Betweenness Uniprot Code
Aldoa 14 0.055213 P05065
HSPD1 14 0.055388 P63039
Pgam2 14 0.060204 P16290
Mapk3 16 0.030572 P21708
SLC2A4 17 0.297383 P19357
Ctnnb1 24 0.133282 Q9WU82
Ywhab 25 0.153595 P35213
HSPA8 29 0.31212 P63018
GAPDH 30 0.11042 P04797
Actb 46 0.30541 P60711
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Table 5. The Concerned Pathways of Differentially Expressed Proteins in Diabetic Retinopathy Rats Versus Normal Group (P < 0.05)
R GO ID GO Term No. Associated Gene Found
1  GO:0010226 Response to lithium ion 3 Calr, impa1, ctnnb1
2  GO:0046686 Response to cadmium ion 3 Sod1, hspa8, ctnnb1
3  GO:0050821 Protein stabilization 4 Calr,pfn2, hspa1b, gapdh





Impa1, hspa1b, akr1b1, atp5b, pdk2, gapdh, eno2, aldoa, pgam2, tpi1, 
eno1, mdh2, qdxk
Figure 2. PPI Network With 33 Nodes and 14 Multi-Edge Node Pairs 
in Diabetic Retinopathy Rats Before and After Laser Therapy. The 
larger circles correspond to the higher degree and blue to brown 
color refers to increment of betweenness value. 
topological parameters of these networks, such as average 
closeness centrality and average shortest path length were 
calculated and shown in Tables 3 and 6. Graph centrality 
properties include essential parameters like degree, 
betweenness and closeness centrality in a PPI network.32 
One of the important properties of a network is the 
degree centrality that is related to the node connectivity 
(the number of connections of a node). A node with high 
degree value is known as a hub node. Another important 
component in network analysis is betweenness, which 
is one of the most important topological properties of 
a network. Bottlenecks that are key connector proteins 
have been introduced as proteins with a high betweenness 
centrality (nodes that many “shortest paths” pass through 
them).28 In system biology, there are some researches that 
have focused on hubs while others have argued bottlenecks 
are more crucial proteins.28 Therefore, we further focused 
on both features of high degree and high betweenness to 
obtain a better predictor of protein essentiality in both 
regulatory and interaction networks. The topologically 
significant nodes for both networks were extracted as 
hubs and bottlenecks as the proteins that were in the top 
10% in both terms of degree and betweenness centrality. 
The determined hubs and bottlenecks for the two states 
are shown in Tables 4 and 7. There are 10 and 3 hub and 
bottleneck proteins for RD and treated states respectively. 
As shown in Tables 4 and 7 the hub proteins are also 
bottlenecks. The introduced hub-bottleneck proteins for 
disease state are Aldoa, HSPD1, Pgam2, Mapk3, SLC2A4, 
Ctnnb1, Ywhab, HSPA8, GAPDH and Actb. ALDOA is 
a key enzyme in glycolysis and acts in regulation of cell 
proliferation and actin cytoskeleton organization.33,34 It is 
reported that the anti-aldolase autoantibody serves as a 
useful marker for DR diagnosis.35 HSPD1 or HSP60 plays 
a key role in preventing apoptosis as well as immune 
response.36 Expression of HSPD1 increases in dry eye.37 
Differential gene expression of HSPD1 in retinoblastoma 
compared to normal retina is reported.38 In addition, 
age-related changes in expression of heat-shock proteins, 
including HSPD1 is reported in rats.39 PGAM is a 
glycolytic enzyme that catalyzes the reversible conversion 
of 3-PGA to 2-PGA.40 This enzyme is up regulated in 
many human cancers.41 However, there was no obvious 
evidence of its relation with retinopathy until now. Mapk3 
acts in a signaling cascade that regulates various cellular 
processes such as proliferation and cell cycle.42 Alteration 
Table 6. Properties of PPI Network of Diabetic Retinopathy Rats Before 
and After Laser Therapy
Topological Parameters Values
Number of nodes 33
Multi-edge node pairs 14
Average degree 3.43
Average betweenness 0.104
Average closeness centrality 0.497
Network density 0.074
Table 7. The Key Nodes (Hub-Bottleneck Proteins) of PPI Network of 
Diabetic Retinopathy Rats Before and After Laser Therapy
Gene Name Degree Betweenness Centrally Uniprot Code
ENO1 9 0.266403 P04764
ALDOA 14 0.264471 P05065
GAPDH 30 0.489767 P04797
Table 8. Pathways of Differentially Expressed Proteins in Diabetic 
Retinopathy Rat Before and After Laser.





2 Pyruvate metabolic process 3 Gapdh, Endo1, Aldoa
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in activation of Mapk3 influences cancer development.43,44 
This enzyme is involved in the release of VEGF in 
diabetic rat retina; therefore, it may be a potential 
therapeutic target of DR.45 Ctnnb1 encodes β-catenin and 
regulates the coordination of cell–cell adhesion and gene 
transcription46 as well as acting as an intracellular signal 
transducer in the Wnt signaling pathway.47 Its abnormal 
expression leads to various diseases including cancer.48 
WNT/β-catenin signaling also is introduced as a new link 
between diabetes and cancer.49,50 A role for β-catenin in 
glucose and energy homeostasis is reported.51 Inhibition 
of connective tissue growth factor overexpression in DR 
via blocking the WNT/beta-catenin pathway confirms 
the association of beta-catenin with DR.52 Ywhab encodes 
a protein that is involved in signal transduction and 
plays a role in cell cycle.53 This protein as a member 
of the 14-3-3 protein family plays a key role in cellular 
proliferation and development of breast cancer.54 The 
report of 14-3-3 proteins relationship with DR is limited 
to a study that shows expression change in early diabetic 
rat retinal proteomes versus normal.25 Chaperones like 
HSPA8 increase cell survival55 and play a key role in the 
maintenance of epithelial cell structure and function and 
are also responsible for cell repair processes after damage, 
proliferation, apoptosis and modulate cell signaling.56. 
HSPA8 protective role was further highlighted in a study 
that identified HSPA8 alongside other HSP70 proteins 
suppressed aging brains.57 Actin, cytoplasmic 1 with 
highest score among the hub-bottleneck proteins has a 
conserved gene in eukaryotes, which play an essential role 
in retina development.58 Glyceraldehyde-3-phosphate 
dehydrogenase (GADPH) is a critical enzyme in glucose-
induced apoptosis of retinal Muller cells.59 Moreover, 
the role of GADPH in the development and progression 
of DR was investigated by Kanwar and Kowluru.60 
Regulation of actin-based motility by Rho was introduced 
as an important pathway according to analysis of the DR 
saliva.61 ENO1 is a hub-bottleneck in treated network. 
Its overexpression has been associated with multiple 
tumors.62-64 In many of these tumors, ENO1 promoted 
tumorgenesis via activating and regulating the PI3K/
AKT signaling pathway.63 It is shown that the knockdown 
of ENO1 expression led to suppressed cell growth and 
migration by inactivating the PI3K/Akt pathway in 
glioma cells.63 Tear proteomic analysis of patients with 
type 2 diabetes with dry eye syndrome shows alteration 
in expression of ENO165 as well as results on DR in rat.25 
Another hub-bottleneck after laser therapy is ALDOA, 
which can be suggested as a common hub-bottleneck for 
DR progression and laser therapy. It is introduced as a 
potential metastasis-associated marker of lung squamous 
cell carcinoma.66 Aldolases A and C are mainly involved 
in glycolysis67 and glycolysis itself has been reported to 
be increased in DR.68 Some data demonstrate that the 
anti-aldolase autoantibody can serve as a useful marker 
for DR diagnosis because of high level in serum35; 
interestingly, following laser treatment the ALDOA 
expression decreased in DR.26 The alteration of glycolysis 
in laser therapy of diabetic retina may reflect metabolic 
improvement caused by laser treatment. GAPDH is 
another common hub-bottleneck protein for the 2 
networks, which has highest centrality score. GAPDH is 
the key glycolytic enzyme. Increase in glycolysis, specially 
overexpression of GAPDH is considered as an essence of 
many types of cancer.69 Non-glycolytic role of GAPDH in 
cancer by interacting with telomerase RNA component 
is reported.70 Diacylglycerol (DAG) is a key activator of 
protein kinase C, it increases glycolysis and endothelial 
cell proliferation as well as endothelial permeability.71,72 
Down regulation of aldolase A and GAPDH after laser 
treatment26 can control the hyper activity of glycolysis 
which occurs in DR patients.68 Agents that regulate 
GAPDH can be potential candidates in inhibiting the 
progression of DR.73 In this study, we introduced 3 hub-
bottleneck proteins that are involved in laser treated DR 
rats. Two of these key proteins (66%) are in common with 
the central proteins that differentiate DR rats from the 
healthy groups; so, it can be concluded that the treated are 
approximately normalized towards the healthy rats.
The GO pathway clusters enriched by crucial proteins 
in DR rats versus healthy controls (see Table 5) provide 
a series of candidates for mechanism research, such 
as response to lithium ion, response to cadmium ion, 
protein stabilization, and response to heat and pyridine-
containing compound. Their role is plausible as most of 
the enriched pathways including protein stabilization, 
and response to heat pathways were previously shown 
to be associated with DR.74-76 The related GO pathway 
clusters after laser therapy are determined as columnar/
cuboidal epithelial cell development and pyruvate 
metabolic process (see Table 8). DR involves an abnormal 
pathology of major retinal cells, including retinal pigment 
epithelium, inter-retinal edema, microaneurysms.77 So 
involving the pathway in epithelial development such 
as columnar/cuboidal epithelial cell development is 
not unexpected. This process is involved in most of 
the mentioned characteristic features of RD and the 
introduced crucial proteins are attributed in regulation 
of this process. Pyruvate metabolic process is another 
detected pathway. Pyruvate is the end-product of 
glycolysis78 and its dysmetabolism contributes to failure 
of the pancreatic islet β-cells during late type 2 diabetes.79 
Its up regulation can lead to excessive fatty acid oxidation 
and ROS formation in the mitochondria.80
 Conclusion
Aldoa, HSPD1, Pgam2, Mapk3, SLC2A4, Ctnnb1, Ywhab, 
HSPA8, GAPDH and Actb are the 10 key proteins in 
PPI network of DR rats. However ENO1, ALDOA and 
GAPDH are the 3 central proteins related to treatment 
of DR rats by laser. This provides molecular evidence in 
support of therapeutic effect of laser.
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